Casi Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?
CASI PHARMS INC has seven approved drugs.
Drugs and US Patents for Casi Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Casi Pharms Inc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077021-001 | Nov 23, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Casi Pharms Inc | ENTECAVIR | entecavir | TABLET;ORAL | 206672-002 | May 11, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Casi Pharms Inc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077310-001 | Nov 8, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.